Podcasts about advancing

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/QHH865. CME/NCPD/CPE/AAPA credit will be available until October 21, 2026.Advancing PBC Care Through Timely Referral and Treatment: From Diagnosis to Long-Term Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Google's Quantum Leap and the Advancing AI Frontier Guest: Brandon Weichert Brandon Weichert discusses Google's Willow quantum chip, which has achieved verifiable quantum advantage, surpassing supercomputers by a factor of 13,000. This breakthrough contrasts sharply with Microsoft's contested Majorana chip, which remains unproven. Weichert notes the rapid evolution of AI systems, including Grok and ChatGPT, each advancing in sophistication at an accelerating pace. He emphasizes that the future demands pairing artificial intelligence with quantum technology to unlock transformative computational capabilities beyond current limitations. 1941

Scaffolding is the technique of providing support and gradually withdrawing support until an individual can perform a task independently. This approach is inspired by Vygotsky's theory of the Zone of Proximal Development. Dr. Ainslie, Dr. Hebert, and Dr. Luke discuss the use of the scaffolding model and how that method can be used for scaling complexity within Nurse Practitioner (NP) curricula. Learn more about this strategy in their article in Nurse Educator.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456 Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices. Episode resource links: Charles, D. N., Nagarsheth, M., & Oshman, L. (2025). Pain Management for IUD Insertion in Primary Care. American Family Physician, 111(4), 299-301. Dempsey, A., Aucoin, C., Stallings, W., Kulangara, A., & Sundstrom, B. (2025). Beyond pain medication: striving toward more patient-centered placement of intrauterine devices. Contraception, 110944. Estevez, E., Hem-Lee-Forsyth, S., Viechweg, N. D., John, S., & Menor, S. P. (2024). Advancing pain management protocols for intrauterine device insertion: integrating evidence-based strategies into clinical practice. Cureus, 16(6). Hoover, K., & Riley, K. (2025). Pain Management for In-Office Uterine and Cervical Procedures. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-456 Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices. Episode resource links: Charles, D. N., Nagarsheth, M., & Oshman, L. (2025). Pain Management for IUD Insertion in Primary Care. American Family Physician, 111(4), 299-301. Dempsey, A., Aucoin, C., Stallings, W., Kulangara, A., & Sundstrom, B. (2025). Beyond pain medication: striving toward more patient-centered placement of intrauterine devices. Contraception, 110944. Estevez, E., Hem-Lee-Forsyth, S., Viechweg, N. D., John, S., & Menor, S. P. (2024). Advancing pain management protocols for intrauterine device insertion: integrating evidence-based strategies into clinical practice. Cureus, 16(6). Hoover, K., & Riley, K. (2025). Pain Management for In-Office Uterine and Cervical Procedures. Guest: Mariyan L. Montaque, DNP, FNP-BC   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

This episode of the California Sports Lawyer Podcast with Jeremy Evans features an insightful conversation with Amy Privette Perko, Chief Executive Officer of the Knight Commission on Intercollegiate Athletics. Perko discusses her distinguished career in college athletics, from her time as a student-athlete and NCAA leader to her role guiding the Knight Commission's national efforts to promote integrity, education, and fairness in college sports. The conversation explores how governance reforms, athlete-centric policies, and financial transparency are reshaping the future of intercollegiate athletics. This episode is a must-listen for professionals, administrators, and students passionate about sports law, policy, education, and leadership — offering valuable lessons on how institutions and leaders can balance competitive sports and business excellence with academic values.  (Season 7, Episode 42). Copyright 2025. California Sports Lawyer. All Rights Reserved. (www.CSLlegal.com) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“Hard things are worth doing.”In this powerful episode of the Special 2025 Healthcare in the Age of Personalization Series, pediatric neurosurgeon Dr. Amanda Saratsis shares why purpose, grit, and leadership are essential to reclaiming dignity in healthcare — especially for our most vulnerable patients.Here's what Dr. Saratsis reveals:• Why surgical precision and musical discipline go hand-in-hand• How physician burnout is tied to standardized systems that dehumanize care• Why pediatric cancer is rising — and what needs to change fast• How technology and personalization are reshaping trust at the bedsideIt's an urgent call for healthcare leaders to lead with empathy, act faster, and never forget who they're here to serve.---------------------------------------------------------------------------------------------------------------------------

Die EU diskutiert kurz vor der COP30 über den Klimaschutz, in Panama berät man über den Schutz von Ökosystemen und Biodiversität und in Chemnitz werden Klimapioniere ausgezeichnet. Das alles in dieser Folge KLIMANEWS am 27. Oktober 2025.Weiterlesen:taz: EU-Gipfel: Industrie wichtiger als KlimaTABLE BRIEFINGS: EU-Klimapolitik: COP-Mandat beschlossen und ETS-2-Anpassung auf dem Wegn-tv: Banaszak rügt "Führungsversagen": Entsetzte Grüne gehen Merz nach EU-Gipfel hart anTagesspiegel Background: EU-Gipfel: Europäischer Rat macht Weg frei für 2040-KlimazielNaturschutzjugend auf Instagram CIGAR: From science to action: Advancing the Global Biodiversity Framework at SBSTTA-27EFE: Arranca en Panamá la reunión de la ONU sobre los avance de la biodiversidad de cara a las COPDBU: Deutschen UmweltpreisSüddeutsche Zeitung: Auszeichnung - Steinmeier beim Umweltpreis: Klima nicht vernachlässigenWir freuen uns über Feedback und Kommentare zu den Themen der Folge direkt auf Spotify, auf Instagram, Twitter oder in unserem Podcast-Telegram-Kanal. Allgemeine Anregungen oder Fragen? Schreib uns! redaktion@klimanews-podcast.de. Die täglich wichtigsten Klima-Nachrichten-Artikel findest du außerdem in unserem Hauptkanal auf Telegram. Empfehle diesen Podcast weiter! Mehr Infos findest du hier.Hier ist der Link zum Spendentool Betterplace. Danke für Deine Unterstützung!Redaktion: Jonathan Auer, Bela Merkes (Redaktion vom Dienst) Moderation, Produktion & Schnitt: Jonathan Auer

In this episode, host Daniella dos Santos is joined by Rachel Malkani, Marie Erwood, and David Singleton from IVC Evidensia's Research Team to discuss the vital role of research in shaping modern veterinary practice.The conversation explores how evidence-based strategies are transforming clinical standards and advancing animal welfare. The team shares their focus for the year on responsible parasiticide usage, a crucial area for both animal health and environmental sustainability.They also introduce the Care Frameworks—a practical tool designed to turn research findings into actionable insights for clinicians. By bridging science with practice, these frameworks aim to strengthen collaboration with pet owners and ultimately improve the standard of care for animals everywhere.Our Guests: Rachel Malkani Rachel is IVC Evidensia's Group Clinical Research Lead. She leads on the annual research strategy, research support, and research training, and is also involved with the care frameworks and other evidence-based requests. Marie Erwood  Marie a data scientist who started her career working in academic research for human health. She uses data to help measure the impact of research at IVC Evidensia and collaborate on internal and external research projects. David Singleton Davis is Group Director of Research at IVC Evidensia. He is a veterinary surgeon with a master's degree and a PhD in epidemiology and health informatics from the University of Liverpool. Collectively, he has first or co-authored over 40 publications.  Our Host: Daniella dos Santos BSc BVetMed FRCVS  Daniella graduated from the Royal Veterinary College in 2012 having previously obtained a degree in Molecular Genetics from Kings College. She has since worked in first opinion, small animal and exotic pet practices across the Southeast. In 2019, she became the youngest-ever President of the British Veterinary Association, leading the profession through the height of the pandemic. During her time as President, she was instrumental in the association's Diversity and Inclusion work, as well as the development and launch of the Good Workplaces Policy. Daniella was the recipient on the RCVS Inspiration Award 2021 for her leadership and became an RCVS Fellow in 2021 for Meritorious Contributions to the Profession. She is a trustee of the animal welfare charity SPANA and the PetPlan Charitable Trust. Powered by IVC EvidensiaAt IVC Evidensia we're building the world's best veterinary group, with a single purpose; healthy animals and happy owners.Visit ivcevidensia.co.uk to find out more, or follow us on social media.Please note that the views expressed by hosts and guests in this podcast do not necessarily reflect those of IVC Evidensia.LinksFor IVC Evidensia colleagues visit the Research Hub on the IntranetTo contact the research team email: research@ivcevidensia.com 

In this podcast episode, Jokūbas Leikauskas, Editor, BioInsights, speaks to Trevor Hallam, who served as Chief Scientific Officer of Sail Biomedicines until July 2025. The interview, recorded in June 2025, explores advances in RNA therapeutics, particularly circular RNA (circRNA or eRNA) technologies, and how they may help overcome current limitations in delivery, durability, and specificity for applications such as CAR-T cell therapies and autoimmune disease treatment.

This episode features Heather Tamborino, CFO at EmblemHealth, who discusses the company's $2 million investment in food security across New York City. She shares how EmblemHealth's neighborhood care centers are addressing food insecurity, connecting social and medical care, and redefining health equity as both a mission and a strategic imperative.

Li Hongyi, Director of Open Government Products, and Jeremy Au discuss how leaders can define, measure, and sustain real performance within organizations. They unpack why clarity of purpose matters more than ambition, how to design fair and motivating systems, and how to prevent burnout in high-performing teams. Their conversation bridges lessons from public service and startups, showing how structure, accountability, and empathy build lasting excellence. 00:56 What is performance: Hongyi explains that success begins with clarity. Teams fail when they skip defining what “high-performing” means before chasing results. 03:15 Why clarity matters more than profit: In the public sector, lacking a clear anchor like profit causes teams to chase noise instead of purpose. 06:43 Designing the right metrics: He suggests tracking three to five key metrics that collectively prevent failure while balancing usability, reliability, and cost. 12:44 Communication through signposting: Hongyi shares that being explicit with intent by saying “this is advice” or “this needs to be done” reduces confusion and builds trust. 14:15 Rethinking performance reviews: Self, peer, and manager evaluations should gather information for better decisions rather than serve as political rituals. 27:00 The danger of over-promotion: Advancing too quickly can destroy confidence and create anxiety. Steady, sustainable growth builds stronger leaders. 31:00 Burnout and sustainable success: True progress comes from building skills, not just adding hours. Leaders must create space for learning and recovery. Watch, listen or read the full insight at https://www.bravesea.com/blog/li-hongyi-measure-what-matters Get transcripts, startup resources & community discussions at www.bravesea.com WhatsApp: https://whatsapp.com/channel/0029VakR55X6BIElUEvkN02e TikTok: https://www.tiktok.com/@jeremyau Instagram: https://www.instagram.com/jeremyauz Twitter: https://twitter.com/jeremyau LinkedIn: https://www.linkedin.com/company/bravesea English: Spotify | YouTube | Apple Podcasts Bahasa Indonesia: Spotify | YouTube | Apple Podcasts Chinese: Spotify | YouTube | Apple Podcasts Vietnamese: Spotify | YouTube | Apple Podcasts #PerformanceCulture #LeadershipDevelopment #OrganizationalClarity #PublicSectorInnovation #BurnoutPrevention #MetricsThatMatter #AccountabilityInAction #TeamBuilding #WorkplaceGrowth #BRAVEpodcast

This episode is brought to you by Aptean. As food and beverage processors seek ways to operate efficiently while monitoring and maintaining food safety and a traceable supply chain, they're looking for advanced technology to help them achieve their goals. Jack Payne, solution consulting director, Food & Beverage and Process Manufacturing, for Aptean, and a longtime industry expert in the field, shares his insights on the innovations that have driven the industry forward, and how a shared passion for serving the best quality, safest food and beverage products has shined through in nearly every partnership he's developed with processors. Learn more about Aptean.

Brodie Sutherland of Tocvan Ventures provides an introduction to the company and the Gran Pilar Gold-Silver Project in Sonora, Mexico. The company recently announced the mobilization of equipment to site for the upcoming drilling, trenching activities, and ground preparation for the planned pilot mine operation. The first drill rig is also set to mobilize to the North Alteration Zone, positioning the Company to accelerate its exploration and development efforts.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent news about drug-resistant infections. Later, Paul Jannetto, Ph.D., director of the Clinical and Forensic Toxicology Lab, Clinical Mass Spectrometry Lab, and Metals Lab, joins Dr. Pritt for the deep dive segment. Together, they explore how diagnostics are shaping the future of therapeutics.  New podcast format launch (00:25): Drs. Morice and Pritt introduce the exciting new format for “Answers From the Lab,” including the addition of in-depth expert segments.   Drug-resistant infections (02:05): Discover how clinical diagnostics play a critical role in combating the growing threat of antibiotic resistance. Diagnostics' role in advancing precision medicine (13:28): Learn how diagnostics, specifically drug monitoring, are advancing personalized therapies and contributing to better outcomes. Note: Information in this post was accurate at the time of its posting. Resources Therapeutics testing: A clear path to accurate answers Therapeutics testing at Mayo Clinic Laboratories WHO warns of widespread resistance to common antibiotics worldwide Tests for infectious disease detection and identification  Connect with Us Is there a question or topic you'd like us to explore in a future episode? Email us at mayocliniclabs@mayo.edu. Learn more about our hosts and guests and connect with them on social media.  Bobbi Pritt, M.D.  Bio  |  LinkedIn Bill Morice, M.D., Ph.D. Bio  |  LinkedIn Paul Jannetto, Ph.D. Bio  |  LinkedIn

We love to hear from our listeners. Send us a message.On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and blindness. Culley shares how Lineage's allogeneic, off-the-shelf approach, anchored by its OPC1 program, aims to replace lost or damaged cells to restore function, starting with patients who have plateaued after chronic spinal cord injury. He details the DOSED study's innovative delivery device and thaw-and-inject formulation, both designed to simplify administration, enhance safety, and improve patient access. Harris and Culley also explore Lineage's broader vision for commercial viability in cell transplantation and its collaborative work with the Christopher & Dana Reeve Foundation to drive awareness, research, and investment in spinal cord injury therapies.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

Welcome to Episode 149 of the Think UDL podcast: Advancing Learning with Nicole Parsons. Dr. Nicole Parsons is an Associate Professor and the Co-Director of the Program for Advancement of Learning or PAL at Curry College in Milton, Massachusetts. I was impressed by the PAL program when I heard about it at a recent conference and also the important UDL research they are doing to advance learning for their students. If you want to learn more about UDL interventions in statistics classes, listen to episode 148 of this podcast: Students Tell Us What Works in Statistics with Jen McNally and Laura Callis. In today's episode, Nicole Parsons and I discuss the program for advancement of learning (PAL) in general and how this brings down barriers for students at Curry College.

Advancing in adversity is possible when our focus remains on God and His kingdom. We all encounter difficulty at some point in life—but even in those moments, God is near and working for our good. In this message, Bill Johnson shares revelation and wisdom for navigating seasons of adversity. Be encouraged by the unchanging nature of God and be reminded that every challenge holds the potential for deeper intimacy with Him. Let this message strengthen your faith and equip you to move forward with renewed hope. With God, it's not only possible to stand in adversity—we are empowered to advance through it.

SummaryIn this engaging conversation, Sean M Weiss and Terry Fletcher explore the evolving landscape of healthcare in 2025, emphasizing the importance of reflection on career paths, the integration of AI in healthcare, and the vast opportunities available within the industry. They discuss the significance of passion in one's career and the need for continuous learning and adaptation in a rapidly changing environment.TakeawaysThis is an interesting year for healthcare professionals.The AMBA conference highlighted the importance of in-person networking.Reflecting on career goals is essential, especially at year-end.AI is a powerful tool but requires human oversight.Healthcare offers diverse career paths beyond traditional roles.Collaboration between billing and coding professionals is crucial.Understanding compliance is vital for all healthcare roles.Passion for the job can lead to greater job satisfaction.Continuous learning is necessary to stay relevant in healthcare.There are many resources available for career development in healthcare.

MLB.com Blue Jays Reporter Keegan Matheson joined OverDrive to discuss the Blue Jays advancing to the World Series, the team's journey for the season, George Springer's incredible home run and his iconic year, Bo Bichette's status to play against the Dodgers, John Schneider's legacy and more.

In this episode, Nick Wilson of Philips Ambulatory Monitoring and Diagnostics and Darren Batara of a leading academic medical center share how health systems can elevate cardiac care through interoperability, operational AI, and strong clinical partnerships that keep patients and clinicians at the center of innovation.This episode is sponsored by Philips.

In episode 94 of Venture Everywhere the host is Cristian Ponce the CEO of Tetsuwan Scientific, an early-stage company developing software to help scientists operate laboratory automation systems. He talks with Dr. Niamh O'Hara, co-founder and CEO of Biotia, a healthtech company using genomics and AI to fight infectious diseases. She shares how a vision to modernize diagnostics and close the gap in infectious disease detection inspired her to spin Biotia out of Cornell Tech and bring precision metagenomics to market. She opens up about how Biotia bridges the worlds of science and entrepreneurship to accelerate the future of infectious disease diagnostics.In this episode, you will hear:Advancing infectious disease testing with genomics and AITurning academic research into scalable healthtech innovationBuilding faster, more precise pathogen detection toolsCombating antimicrobial resistance through smarter diagnosticsExpanding into women's health and clinical partnershipsLearn more about Niamh O'Hara | BiotiaLinkedIn: https://www.linkedin.com/in/niamh-b-o-hara Website: https://www.biotia.io Learn more about Cristian Ponce | Tetsuwan ScientificLinkedin: https://www.linkedin.com/in/cristian-ponce5 Website: https://tetsuwan.com

This episode is sponsored by IDEXX This podcast episode, hosted by Adam Christman, DVM, MBA, features oncologists Dana Connell, DVM, MPH, DACVIM (Oncology) and Zachary L. Neumann, DVM, MS, DACVIM (Oncology), discussing the significance of early cancer detection in dogs. The conversation focuses on the IDEXX Cancer Dx testing. The doctors explain how the test, which can be included in routine wellness exams, provides rapid results, enabling veterinarians to make timely diagnoses and improve treatment outcomes. They also touch on the importance of the veterinary team in communicating sensitive news to pet owners and the future potential of the test to screen for other types of cancer.

The global focus on climate resilience is evolving to emphasize adaptation alongside mitigation, a key theme highlighted at this year's Climate Week NYC. This is fueling increased demand for comprehensive risk management strategies that integrate advanced analytics and innovative insurance solutions to address escalating climate risks.  In this episode of Risk in Context, Marsh's Amy Barnes and Julie Milbrand, Marsh McLennan's Francis Bouchard, and Guy Carpenter's Kieran Bhatia discuss how the insurance industry is advancing technical capabilities and innovating solutions to tackle rising climate risks. They also explore how improved climate risk analytics are enhancing investment decisions and the critical role of multi-stakeholder collaboration in accelerating the adoption of effective resilience measures. You can access a transcript of the episode here. Read Marsh's 2025 Corporate Adaptation Survey and our report, Tackling the heat challenge. For more insights and insurance and risk management solutions, follow Marsh on LinkedIn and X and visit marsh.com.

Uli Chettipally, founder of Sirica Therapeutics, joins EisnerAmper's TechTalk host Janina Teoxon to discuss how his digital health startup is developing a groundbreaking therapy for individuals with autism spectrum disorder (ASD). In this episode, discover how Sirica Therapeutics' proprietary Cognitive Sensorimotor Therapy blends virtual reality, gaming, robotics, and physical exercise to create an immersive therapeutic system. Tune in to learn more about Sirica Therapeutics' mission to transform autism care, bringing joy, empowerment, and meaningful progress to individuals and families affected by ASD. Sirica Therapeutics: https://www.siricatx.com/ Connect with Dr. Uli Chettipally: https://www.linkedin.com/in/ulichettipally/ ✨ What you'll learn:

This episode features Heather Tamborino, CFO at EmblemHealth, who discusses the company's $2 million investment in food security across New York City. She shares how EmblemHealth's neighborhood care centers are addressing food insecurity, connecting social and medical care, and redefining health equity as both a mission and a strategic imperative.

This week on Veteran On the Move, we welcome Tony Crescenzo, a Marine Corps veteran whose incredible journey spans from counter-intelligence and working undercover for NIS (NCIS) to the technology C-suite. Tony shares his remarkable pivot from military life, including a wrongful court-martial that was later overturned, into becoming a sought-after "CEO for hire" for tech startups. He emphasizes the essential role of veteran mentors in a successful transition. Listen in as he breaks down the stages of business growth, detailing what military leaders uniquely bring to the civilian sector, the power of a "service-first ethos," and the critical difference between leadership and management. Finally, Tony introduces Peak Neuro explaining how its programs are helping veterans and first responders achieve peak cognitive resilience and accelerating recovery. Episode Resources: - Peak Neuro - Text Peak Trial to 201-908-2820 for a free 30 day trial      About Our Guest Tony Crescenzo is the Chief Executive Officer of Intelligent Waves, a mission-focused IT and cybersecurity firm serving national security customers, and the Founder of Peak Neuro LLC, an AI-enabled neuroscience venture advancing cognitive resilience. A U.S. Marine Corps veteran, he leads with a service-first ethos (generals eat last), clear leaders intent, and rigorous accountability. At IW, hes driven growth in secure communications, cloud, and cyber operations while building a trust-centric culture. At Peak Neuro, he champions Post-Cognitive Symbolic Regulation™ (PCSR) and the NeuroEdge™ programs (Reclaim, Elite, Enforce) to help veterans, first responders, and elite professionals accelerate recovery and sustain peak performance. A frequent speaker on culture, ethics, and human performance, Crescenzo translates Marine-forged principles into measurable outcomes for missions and people.   About Our Sponsors Navy Federal Credit Union   Whether you're looking to buy a new or used car or maybe you want to refinance your current car loan, Navy Federal Credit Union has great rates on auto loans and discounts for Active Duty servicemembers and Veterans. You can apply via their mobile app or online and, in most cases, get a decision in seconds. For those of you looking to refinance your current auto loan, you could get $200 cash back when you refi your loan from another lender. Find out more at navyfederal.org/auto.  At Navy Federal, our members are the mission.    Join the conversation on Facebook! Check out Veteran on the Move on Facebook to connect with our guests and other listeners. A place where you can network with other like-minded veterans who are transitioning to entrepreneurship and get updates on people, programs and resources to help you in YOUR transition to entrepreneurship.   Want to be our next guest? Send us an email at interview@veteranonthemove.com.  Did you love this episode? Leave us a 5-star rating and review!  Download Joe Crane's Top 7 Paths to Freedom or get it on your mobile device. Text VETERAN to 38470. Veteran On the Move podcast has published 500 episodes. Our listeners have the opportunity to hear in-depth interviews conducted by host Joe Crane. The podcast features people, programs, and resources to assist veterans in their transition to entrepreneurship.  As a result, Veteran On the Move has over 7,000,000 verified downloads through Stitcher Radio, SoundCloud, iTunes and RSS Feed Syndication making it one of the most popular Military Entrepreneur Shows on the Internet Today.

In this episode, David Harding, Senior Vice President of Pipeline Product Management at Exact Sciences, discusses a new survey of healthcare executives on multi-cancer early detection. He shares insights on system readiness, patient demand, and the barriers health systems face in adopting this transformative approach to cancer screening.This episode is sponsored by Exact Sciences.

God has promised us something in the future that is far, far greater than the Paradise that Adam and Eve enjoyed. Dr. Ross gives us just a glimpse of what we Christians have to look forward to in the future. To support this ministry financially, visit: https://www.oneplace.com/donate/701/29

Years ago in Juarez, Mexico, I wandered into a carnival sideshow that flabbergasted this Texas country boy. Stumbling out, I murmured: “Now I've seen everything… and then some.” But now, decades later, I've been even more stupefied by the news that convicted Wall Street swindler Michael Milken has just opened his own bizarre freak show in Washington, DC.Touted as a “tourist attraction,” his museum glorifies predatory capitalists (like him), hailing them as heroic American geniuses! The infamous junk-bond scammer grandiosely labels his monument the Milken Center for Advancing the American Dream. It's located right across the street from the White House (though it's rumored that even his buddy Trump considered Michael's “Monument to Mammon” to be too explicitly obscene to attach it directly to the East Wing).In a perverse bit of symbolism, the thing occupies the former headquarters of a bank that was forced to close 20 years ago because of a money-laundering scandal. How's that for Karma? But, to gloss over such ugliness, Milken has gilded his legacy mausoleum with Trumpian gold. The rooms, draperies, furniture – and even a fake tree in the atrium – all gleam with gold leaf, emphasizing Milken's credo that the goal of life is money… and the power to get it.Educational exhibits include an interactive game on compound interest, as well as a display of Mike's high school cheerleading uniform. Missing, though, is any mention of the full presidential pardon this avaricious criminal wrangled from Trump in 2020, letting the racketeer escape prison for stealing a billion dollars from people who trusted him.Still, if you visit his Washington freak show, the gift shop offers a memento that sums up his life: A $22 Milken money clip.Jim Hightower's Lowdown is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit jimhightower.substack.com/subscribe

Three decades after the landmark 1995 UN World Conference on Women in Beijing, Gertrude Mongella, Secretary-General of the conference and a pioneer in global women's empowerment, returns to the city for the Global Leaders' Meeting on Women. In an exclusive interview with China Africa Talk, she reflects on the legacy of the Beijing Declaration and Platform for Action, shares her insights on China's growing contribution to global gender equality, and offers her hopes for how future generations of women can live in a fairer and more equal world.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of major advancements and strategic moves that are shaping the future of healthcare.A significant development comes from AstraZeneca, which has committed a substantial $445 million investment to bolster production at its Texas facility for Lokelma, a treatment designed for hyperkalemia. Hyperkalemia is a condition characterized by elevated potassium levels in the blood, posing serious health risks if not managed properly. This investment highlights AstraZeneca's dedication to meeting growing global demand and enhancing patient access to this vital treatment. By strengthening its production capabilities, the company aims to ensure a more reliable supply chain, potentially leading to better outcomes for patients worldwide.Meanwhile, Pfizer is making noteworthy progress in the realm of oncology. Recent clinical trial results have positioned Tukysa, developed in collaboration with Seagen, as a promising candidate for first-line maintenance therapy in HER2-positive breast cancer. The potential shift from second-line to first-line treatment could significantly alter patient care by offering an effective therapeutic option earlier in the disease management process. This advancement underscores Pfizer's commitment to improving long-term outcomes for patients battling this aggressive form of cancer.In legal news, a dispute between Novo Nordisk and KBP Pharmaceuticals has underscored the critical importance of transparency and thorough due diligence in biotech transactions. The controversy involves "anomalous" phase 2 clinical trial results that Novo Nordisk claims were not adequately disclosed by KBP. Such cases highlight the necessity for rigorous investigation during mergers and acquisitions to prevent costly legal battles and ensure informed decision-making in drug development partnerships.On the HIV prevention front, GSK has released promising data for its long-acting pre-exposure prophylaxis drug, Apretude. This new data suggests Apretude holds higher acceptability compared to Gilead's competing product, Yetztugo. Improved patient adherence could shift market dynamics towards GSK's favor, potentially enhancing public health outcomes by preventing HIV infections more effectively.Manufacturing innovations are also taking center stage as Particle Dynamics collaborates with a former EuroAPI plant to introduce Codis, a new contract development and manufacturing organization (CDMO). Codis will offer comprehensive services such as spray drying and particle engineering, aligning with growing demand for specialized pharmaceutical manufacturing capabilities.Turning our attention to diabetes treatment advancements, Eli Lilly's oral GLP-1 candidate Orforglipron has demonstrated superiority over both placebo and AstraZeneca's Farxiga in phase 3 trials for type 2 diabetes. This success strengthens Eli Lilly's portfolio in a highly competitive market and could lead to regulatory approval next year. An oral treatment option could significantly enhance patient compliance compared to existing injectable GLP-1 therapies.In oncology, Boehringer Ingelheim has entered into a deal worth up to $991 million with AimedBio, focusing on antibody-drug conjugates (ADCs) that target proteins involved in tumor growth and resistance. This collaboration highlights the increasing interest in ADCs as targeted cancer therapies capable of minimizing systemic toxicity while delivering potent cytotoxic agents directly to cancer cells.The industry continues to be shaped by funding rounds and strategic acquisitions. Novo Nordisk's acquisition of Omeros' MASP-3 inhibitor Zaltenibart for $2.1 billion marks a significant move in rare disease therapeutics. Despite Omeros pausing development, Novo Nordisk sees potential in treating paroxysSupport the show

Wyman & Bob tell us how they feel about the mariners being only two wins away from getting to their first World Series in team history. They also talk about the huge contributions from Jorge Polanco in this postseason. // This was one of the greatest sports weekends in Seattle history! The Mariners, Seahawks, Kraken, and Huskies all won their games over the weekend! // Take Two: Brewers-Dodgers Game 2 of the NLCS tonight…Blake Snell allowed just one hit in eight innings last night…Yamamoto and Peralta tonight for their respective teams. Falcons and Bears win MNF games last night…Bills lose their 2nd straight and the NFC now has 10 teams over .500 // Wyman & Bob go through the Seahawks win over the Jaguars and break down what stood out to them about the win. // Seahawks Cornerback Shaquill Griffin joins the show to talk about how it felt getting the call back to the roster, playing back in Jacksonville, and how he is bonding with the younger members of the Seahawks defense. 

In this episode, Michael asks you chilling question: “Agree or Disagree — Mitigating the risk of extinction from AI should be a global priority akin to the threat of pandemics and nuclear war.” Michael dives into the warnings from AI experts who argue that artificial superintelligence could mean the end of humanity. From OpenAI's new video generator Sora to the blurring line between fact and fiction, Michael explores whether technology has already gone too far.

Join Darrell Bock and Walter Kim as they explore the mission, context, challenges, and potential solutions of American evangelicalism.   Time codes:   5:33  What is the National Association of Evangelicals?  12:45  Examples of the NAE's Work  19:43  Key Challenges Facing the Evangelical Movement  30:57  Potential Solutions  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join Darrell Bock and Walter Kim as they explore the mission, context, challenges, and potential solutions…

More Chapters

When baby KJ was diagnosed with a rare metabolic disorder, the team at Children's Hospital of Philadelphia (CHOP) had a unique treatment option for him: a personalized gene editing therapy developed in collaboration with Penn Medicine. On this episode, Madeline speaks to CHOP geneticist Dr. Rebecca Ahrens-Nicklas, who describes how KJ's first-of-its-kind treatment was developed – and what this amazing breakthrough means for other patients. 

What evidence does the universe give us about how old it is? How does that evidence compare to what the Bible says? Is there a civil way for Christians to reconcile the two? To support this ministry financially, visit: https://www.oneplace.com/donate/701/29

In this episode, Dr. Gregg Furie and Dr. Wynne Armand share how Mass General Brigham is leading the way in sustainable healthcare through renewable energy investments, emissions reduction, clinician engagement, and education. They discuss the system's progress toward net zero, the connection between climate and health, and practical steps for hospitals beginning their sustainability journey.

In this episode, Dr. Lisa Howley, Director of the Fetal Cardiology Program at Children's Minnesota, discusses the biggest challenges and innovations shaping fetal and pediatric cardiology, including disparities in prenatal detection, the growing adult congenital population, and the promise of AI and telehealth in expanding access to care.

Hour 2 of the Bog Show w/ Rusic & Rose is on demand! For hour 2 the gang are joined by the radio voice of the Toronto Blue Jays, Ben Shulman! Ben breaks down everything that went right and wrong for the jays in their ALDS victory over the New York Yankees! Then he helps us preview the Jays in the ALCS as they await their opponent.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Media Inc. or any affiliate. Get full Flames games and great shows like Quick 60: The Stamps Show, Wranglers Watch and more ON DEMAND.

All the ALDS & NLDS have played two games and the Seattle Mariners vs Detroit Tigers is the only series tied 1-1. The Los Angeles Dodgers, Milwaukee Brewers and Toronto Blue Jays are all just one game away from advancing to the NLCS & ALCS. Ben Verlander is back to recap all the series so far and preview the Game 3's for the Detroit Tigers, Seattle Mariners, New York Yankees & Toronto Blue Jays. Playoff baseball is back! Learn more about your ad choices. Visit megaphone.fm/adchoices

Mike and Rico give their thoughts on the Tigers' game 3 win over the Guardians to advance to the ALDS, wondering if you are willing to forgive Scott Harris for his inaction at the trade deadline.